These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8721950)

  • 21. [The kidney in diabetes].
    Favre H
    Rev Med Suisse Romande; 1995 Sep; 115(9):717-20. PubMed ID: 7481360
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetic nephropathy--what does it cause to develop?
    de Jong PE
    Neth J Med; 1988 Oct; 33(3-4):101-5. PubMed ID: 3067096
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetic nephropathy.
    Martin P
    JAMA; 1977 Feb; 237(8):765-6. PubMed ID: 576306
    [No Abstract]   [Full Text] [Related]  

  • 24. Exchangeable sodium in diabetes.
    Ferriss JB; O'Hare JA
    Diabet Med; 1988 Sep; 5(6):597. PubMed ID: 2974787
    [No Abstract]   [Full Text] [Related]  

  • 25. Microalbuminuria in patients with NIDDM: an overview.
    Alzaid AA
    Diabetes Care; 1996 Jan; 19(1):79-89. PubMed ID: 8720542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of diabetic kidney disease.
    Reutens AT
    Med Clin North Am; 2013 Jan; 97(1):1-18. PubMed ID: 23290726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy.
    Parving HH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes and end-stage renal failure.
    Catalano C; Cuzzola F; Enia G; Maggiore Q
    Lancet; 1987 May; 1(8543):1201. PubMed ID: 2883509
    [No Abstract]   [Full Text] [Related]  

  • 29. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
    J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy: a global and growing threat.
    Tang SC
    Hong Kong Med J; 2010 Aug; 16(4):244-5. PubMed ID: 20683064
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetic renal disease in blacks--inevitable or preventable?
    Rostand SG
    N Engl J Med; 1989 Oct; 321(16):1121-2. PubMed ID: 2797070
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibition in diabetic patients. Economic implications.
    Rodby RA; Lewis EJ
    Pharmacoeconomics; 1996 Oct; 10(4):315-20. PubMed ID: 10163576
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in diabetic nephropathy: how big a culprit is glucose?
    Striker GE; Striker LJ
    Diabetes Metab; 1996 Dec; 22(6):407-14. PubMed ID: 8985648
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetic nephropathy: what are the diabetologist's expectations?
    Passa P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():6. PubMed ID: 10922967
    [No Abstract]   [Full Text] [Related]  

  • 35. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association.
    Diabetes Care; 1992 Nov; 15(11):1673. PubMed ID: 1468300
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiologic analysis of the increase in terminal renal insufficiency associated with type 2 diabetes mellitus].
    Lorenzo V; Martín Urcuyo B
    Nefrologia; 2000; 20 Suppl 5():77-81. PubMed ID: 11190112
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetic nephropathy--are there differences between type I and type II?
    Ritz E; Hasslacher C; Tschöpe W
    Miner Electrolyte Metab; 1990; 16(1):69-72. PubMed ID: 2182996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes: response to Shultis et al.
    Varon FN
    Diabetes Care; 2007 Dec; 30(12):e138; author reply e139. PubMed ID: 18042747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.